The Best in Blend:
Morningstar's Brian Portnoy on Buying Small-Cap Blend Funds

By Richard Hefter, Editor, Small Cap Manager

Typically investors think of analysts as professionals that research stocks. But Brian Portnoy, senior analyst at Chicago-based Morningstar, Inc., has the job of evaluating equity funds. Small-cap blend funds, in particular. This month, we talked to Portnoy about how he assesses funds, which funds he likes, what investors should look for and what the trends are in the small-cap space.

How would you describe your work at Morningstar?

Scott Hood
I'm one of approximately 25 fund analysts. Most of us have a diversified coverage list of 70-100 funds. Each analyst is also assigned one of about 48 investment categories, staying on top of the news and particular funds in that category and also producing a list of fund analyst picks in that category. My category is small-cap blend.

What are the characteristics of small-cap blend?

As the name suggests, the blend category is going to be a mix of growth and value stocks. If you look at valuations across our three small-cap categories - value, blend and growth - it should come as no surprise that the small-cap value funds have the lower price to earnings, price to book, and price to cash flow ratios, and the small growth funds are in the higher spectrum for each of those variables. Small blend is in the middle. Within small blend funds there are some differences - some tilt toward growth and some tilt toward value - but by and large you're going to find middle-of-the-road offerings in terms of valuation, which is why we often say the small blend category is a good place to look for a core small-cap offering.

What do you look for in evaluating funds?

There's a short but important list of features you'd be looking for in any type of equity mutual fund. You want to look at performance, but make sure you understand the market that fund is trying to get ahead in. So you look at performance through up and down markets, and whether the fund is really good in up markets and protects on the downside.

You also want to look at who's managing the fund, what sort of experience they have, and whether that experience is germane to running that sort of product.

You want to look at risk and how the manager conceives of risk and how they've structured the portfolio to deal with different types of volatility. Do they make big bets on stocks? On sectors? Do they keep stock positions small so that no individual stock can hurt performance? Do they go way off on the valuation spectrum, and are they willing to take on a lot of price risk? So, in short, understand what types of risk the fund takes.

Finally, in terms of this broad list of what to look for, I flag expenses. If there's one thing that's proven to directly and significantly impact long-term performance, it's expenses. If your fund is overpriced in terms of its annual expense ratio, then that's going to be a serious drag, more than most people would realize, and will make you less able to meet your investment goals.

What funds do you like best in the small-blend category based on this analysis?

One pick that's at the top of the list is Fidelity Low-Priced Stock (FLPSX). This is a fund whose manager, Joel Tillinghast, just won Morningstar's "Domestic Equity Manager of the Year." He's done an unbelievably good job of managing the portfolio for more than a decade. This is a unique looking fund. He holds anywhere from 700 to 1000 stocks, which is not typical. Most small blend funds hold maybe 100-150 stocks, some a lot less than that. The fund has a very large asset base which is typically a red flag for small-cap investors, but in this particular instance Tillinghast has managed that asset base remarkably well, and his performance on a calendar year and trailing basis is very, very good.

He can get away with diversifying so broadly?

Most people who speak to Joel consider him a genius. My colleagues who have interviewed him over the years typically will pick one of the very bottom holdings in the portfolio, say holding #684, and ask him detailed questions about that stock, and he knows that company as though he has just studied it in-depth.

Any others you like?

Let me mention Royce Premier (RYPRX). The entire Royce family of funds is known for its small-cap line-up. It's a shop that focuses on small-cap stocks, and they have a good number of funds in that space. We picked this one because the managers Chuck Royce and Whitney George have done a very good job over time giving investors a very competent core small-cap exposure. Most of the Royce funds fall in our small-cap value category because it's a valuation-sensitive shop. This one falls in our small-cap blend because they're willing to take on a little bit more price risk. That said, their general sensitivity to valuation has allowed them to hold up relatively well through the bear market in general.

I'd also put FPA Paramount (FPRAX) on the list as well. The managers there, Eric Ende and Steven Geist, have experience at another FPA small-cap fund called FPA Perennial (FPPFX). That has a very good long-term record, while FPA Paramount does not because Ende and Geist just took it over about 2-3 years ago, but they have more or less identical portfolios at this point. Like the Royce Premier Fund, it's very good small-cap exposure. You're going to get a mix of growth and value stocks, but regardless of where the stocks fall on the valuation spectrum, you know these two guys are going to keep valuation in mind, so it's not going to take too much price risk.

Why do you pick one over the other?

We pick Paramount over Perennial because Paramount had some pretty significant losses in the past, and has a sizable tax-loss carry forward. So for those investing in a taxable account the Paramount fund is good because it's going to be tax efficient for quite some time. It's got a lot of losses it can use against gains and therefore neutralize any capital gains payouts going into the future.

Are fees and tax issues more of an issue with small-cap funds than with larger ones?

Small-cap expenses tend to be higher than large-cap. The line you hear is that research is more difficult to do on smaller-cap stocks. In the large-cap space, for example, there's a lot of common knowledge floating out there about, say, AOL, Wal-Mart or General Electric, but with $100 million or $500 million companies Wall Street doesn't know that well, you have that much more of a research effort to understand those companies, and that gets expensive. That's typically the reason given for why small-cap funds are more expensive.

That said, there's a pretty wide spread of expenses across small-cap funds and, because expenses matter so much for long-term performance, investors would be wise to shop for a cheaper small-cap fund, all else being equal.

How can investors limit their tax expenses - choose funds with less turnover?

Turnover isn't always a direct indication of tax efficiency. Typically, when you see a fund with single-digit or low double-digit turnover, they tend to be tax efficient because they're not churning the portfolio and picking up any gains that could be taxed. That said, you could have a higher turnover fund that is managed in a tax-efficient way. The extra turnover could mean that the manager is actively buying and selling positions in order to manage that tax position. So if they're going to be selling something at a gain, they might also sell part of a position at a loss in order to balance out the fund's tax position. You can look on Morningstar or elsewhere for a fund's after-tax performance, and that's important to do because that's the money you actually get to keep. This is all assuming you're investing in a taxable account rather than a tax-sheltered account like a 401(k) where it's not an issue.

Is the size of the fund typically a limitation in the small-cap space?

Yes. I want to emphasize that the Fidelity Low-Priced Stock example is an extreme outlier. A $15 billion small-cap fund is unheard of, except for this one example. When a small-cap fund climbs over $1 billion in size, that's a flag for me as an analyst. That's when I begin to look more closely at the type of securities that it's buying in terms of whether it has to buy more mid-cap stocks, or buy some extra small-cap positions in order to manage risk. When a fund's asset base grows too large, it's cause for concern.

Why?

When a fund's asset base grows too large, it can have one of several impacts for the portfolio going forward. One is that because small caps are relatively illiquid, meaning that they're harder to buy and sell, if a fund has too much money on hand, it might have to start buying mid-cap stocks, which are more liquid, easier to buy, and that could defeat an investor's allocation plan.

Secondly, if a fund has too much money, it could mean the portfolio manager has to hold a lot of cash. They just can't invest the money, so they'll build up a large cash stake, and that might not also be what an investor wants. An investor might want to make his own asset allocation decision in terms of cash held in a portfolio.

And third, if a small-cap fund has a large asset base, it might expand the number of positions. So if the manager's preference is to have a portfolio of 60-70 names, and that's how he or she likes to approach the portfolio in terms of risk management, and if too much money is in the fund then he or she might need to spread his bets even more widely, adding more positions and not running the portfolio as he originally preferred.

Being familiar with both growth and value funds, do you have an opinion on the prospects for small-cap growth versus value?

We don't make those sorts of market calls. I'm not in a position to say one way or another. These things do tend to go in cycles among the small-cap stocks and across the equity universe generally. Value has outperformed growth for three straight years now.

10 Micro-Caps Worth Watching

A Message From Our Sponsor:
By John Dutton, President, JM Dutton & Associates, LLC

As one of the largest independent equity research firms in the U.S., JM Dutton & Associates is helping investors gain high-quality fundamental research on good companies. Prior to our initiation of coverage, many of these companies had little or no research following, and as a result have been under Wall Street's proverbial "radar screen" and trading at prices well below intrinsic value.

Our program of independent research minus any investment banking or brokerage constraints involves a full year of coverage, with an initial report, three quarterly reports, and research notes in between the quarters.

The following are companies we've reported on within the last several weeks, whose reports on our site at www.jmdutton.com may be of interest to you:

Strong Buy Rating Issued For Alaris Medical
January 09, 2003. Alaris Medical (AMI) is a leading worldwide medication delivery and infusion therapy systems company that is ahead of its competitors in driving technology towards higher standards of medication delivery safety and accountability. The Company designs and manufacturers proprietary intravenous medication delivery safety and infusion therapy devices, associated needle-free disposables and related monitoring equipment. Alaris markets these products to over 5,000 hospitals in 120 countries worldwide. The Company has about 2,600 employees and operates manufacturing facilities in the United States, the United Kingdom, and Mexico. Revenues are estimated at $449.5 million in 2002 rising to $554.5 million in 2004, while EPS are estimated at $.11 in 2002, rising to $.34 in 2004. We believe the Company is at the cusp of seeing the net benefit of many changes under new management, which should drive a significantly improved financial performance.

Vita Foods Strong Buy Rating Maintained In Update Report
January 14, 2003. Our optimism for Vita (VSF) is based on its having an established network of food brokers and distributors to effect the national distribution of internally developed new products and specialty products obtained by acquisition. The implementation of the concept began July 2001 with the Virginia Honey acquisition. Proof of the concept is obvious in Virginia Honey's performance in the year just completed, with its business contributing, we believe, 32.2% of the estimated total 2002 net sales and 43.9% to operating income. In November 2002, Halifax Group, another producer of specialty branded dressings and sauces, was acquired, and will be integrated with Virginia Honey to capitalize on Virginia Honey's under-utilized production facility. Net company sales for 2002 should be $41.3 million, 29% above the prior year, with estimated EPS up 38% to $0.43. VSF estimated 2003 revenues and EPS are $44.5 million and $.54 respectively.

Rawlings Neutral Rating Maintained In Update Report
January 16, 2003. On January 9, Rawlings (RAWL) reported results for the seasonally weak Q1 (November) quarter with EPS a loss of $0.08 (vs. $0.10 a year earlier) and substantially in line with our estimate of a $0.09 loss. Q1 net revenues fell 10.3% to $30.0 million, reflecting the impact of the NCAA basketball agreement cancellation. Management reaffirmed that full 2003 fiscal year sales should be substantially flat, which we do not view significantly different from our projection of a 1.4% increase. Management also reaffirmed their belief that cost reductions in place would enable Rawlings to achieve earnings gains even with flat sales. We agree. However, we rate the stock Neutral as the shares are selling at only a modest 5.4% discount to the value of the K2 acquisition offer (based on the current prices of RAWL and K2 shares), and at a premium to the current $8.50/share cash offer from Dan Gilbert.

Questcor Strong Buy Rating Maintained In Update Report
January 13, 2003. Questcor (QSC) is a specialty pharmaceuticals company focused on acquiring or licensing existing high value, high need FDA approved or very late stage pharmaceuticals for certain niche markets in the acute care and critical care arenas. QSC's Q3 results were stronger than expected even considering the one-time front-loading effect of a price increase announced near the end of Q2. The current revenue run rate suggests that the full year results will likely handily exceed management guidance of $12+ million. Furthermore, based upon the current run-rate in revenue, the stock is now trading at only 2.5x 2002 revenue and only 1.9x projected 2003 revenue. As QSC management continues to perform against key operating objectives, the Company should benefit from investor interest in solid growth stories.

The Leather Factory Strong Buy Rating Maintained In Updated Initial Report
January 06, 2003. The Leather Factory (TLF) serves a sub-segment of the $40 billion crafts industry by providing leathercrafting materials to recreational leathercrafters and professional craftsmen through a variety of distribution channels. It currently dominates its market niche, which is leathercrafting tools, materials, and accessories, generating strong financial results over the last few years. The Company's key growth strategy--recreating the Tandy Leather retail chain, combined with its dominant position, can be expected to generate additional profitable growth in future years. Its market valuation does not fully reflect the TLF's recent earnings gains, and it clearly has not taken into consideration the Company's future growth potential. We estimate revenues of $45.8 million in 2003 with EPS rising to $.32.

Advant-e Results In Q3 Provide Evidence Of Growing Acceptance of Its Industry Portals
January 02, 2003. Advant-e's (AVEE) recent Q3 results demonstrate the growing acceptance and use of its portals. Total revenue for Q3 was up 68% over the prior year's quarter, and 11% ahead of the prior quarter. It announced that cumulative purchase orders processed on groceryEC.com, its grocery EDI supply chain solution for small and medium sized grocery suppliers, surpassed $3 billion dollars, and took only four months for the third billion versus six months for its second. Revenues for 2002 estimated at $2 million, increasing to $3.2 million in 2003. EPS in Q4 of 2002 should be a loss of $(.01) and should total $(.04) for 2002. Estimate 2003 EPS to be $.04. Maintaining Strong Speculative Buy.

Teton's Russian Oil Production Rises; Files AMEX Application
January 16, 2003. Teton (TTPT) announced substantial year end increases in its Russian oil production. It files its AMEX application and prepares a 1 for 10 reverse split.

Warrantech Renews Account Relationship With Consumer Retailer
January 16, 2003. Warrantech (WTEC) announced that it had signed an agreement with Desears Appliance and Home Entertainment, who has returned as a client of Warrantech. Key is WTEC's WCPS Online service, a web-based platform introduced early last year, that allows Warrantech's clients to significantly reduce paperwork, while reducing costs associated with administering service contracts. Strong Buy maintained.

Riviera Tool Lowered To Speculative Buy In Update Report
January 15, 2003. Riviera Tool (RTC) is one of the leading tooling firms serving the automobile manufacturing industry, and its revenues are likely to continue to rebound over the next two years. This has been reflected in the strong rebound in their order backlog. However, their margins have been under pressure, due mainly to external industry conditions, and the level of future profitability is difficult to predict at this point. Riviera's auditors issued a conditional letter with the most recent 10-K, due to a lack of renewal of their bank lending agreement. The Company recently announced that it has reached a lending agreement with its current lender and an additional lender. We are changing our rating to Speculative Buy in view of the uncertainties associated with profit margin estimates.

Century Casinos Purchased Balance of Century Casinos Caledon (Pty) Ltd.
January 14, 2003. Century Casinos (CNTY) has purchased the balance of 35% of the entity, Century Casinos Caledon (Pty) Ltd (CCAL). CCAL owns the Caledon Casino, Hotel and Spa that is located near Cape Town, South Africa. The benefit of complete ownership of the facility to CNTY is the management flexibility that goes with total control. We continue to rate CNTY as a Strong Buy.


We invite you to read all of our reports at www.jmdutton.com

I wouldn't be surprised if we saw some rebound in the growth space, but we don't spend our time, and that's not our competence, to evaluate one part of the market versus the other.

It seems from your picks that comfort with the management is key is selecting small-cap funds?

Absolutely, because in the bigger debate on whether investors should buy actively managed funds or index funds, I think the evidence shows that in the small-cap space, which is typically less efficient than the large-cap space, managers can add some value. So you want to take time to research those fund companies and those specific managers that have proven an ability to outpace both their peers and benchmark over time. Certain shops like Wasatch or Royce are well-known for their small-cap investing ability, and other individual funds, whether they be Buffalo Small Cap, or Fidelity Low-Priced Stock, or William Blair Small-Cap Growth, have shown on an individual fund basis that they can outperform over time.

(c) 2003 Small Cap Manager, a publication of AdviceTrade, Inc., and sponsored by JM Dutton & Associates (www.jmdutton.com).


Subscriber Services and Privacy Statement
To unsubscribe or change your subscription, go here.

We encourage readers to review our privacy statement. Go Here


Notice
This issue of Small Cap Manager is being sent to you by Executech Financial Advisors, LLC with permission of AdviceTrade, publisher of Small Cap Manager, and JM Dutton & Associates, LLC (JMD), sponsor of Small Cap Manager. Information, opinions or recommendations contained in this Small Cap Manager interview or in comments made by JMD that relate to research reports referenced in this publication are submitted solely for informational purposes. The information has been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy of the information. In addition, this information and the opinions expressed are subject to change without notice. JMD sponsors AdviceTrade. Neither AdviceTrade nor JMD, their principals, or the assigned JMD analysts own or trade shares of any company covered or of any fund that appears in Small Cap Manager. Equity compensation is not accepted either by JMD or AdviceTrade.

Complete JMD research reports on companies mentioned are available at no charge from JMD's website, www.jmdutton.com. The Small Cap Manager interview and JMD research reports are not intended to be construed as an offer or a solicitation of an offer to buy or sell any security that is mentioned in Small Cap Manager. The fund that is featured in Small Cap Manager does not pay any compensation to AdviceTrade or JMD for the interview. In addition, neither AdviceTrade nor JMD receive compensation from any other party for the interview.

Each of the companies that are referenced in the gray inset entitled "a message from our sponsor" are enrolled for research coverage with JMD. Research coverage with JMD requires a $25,000 prepaid fee for one-year of coverage. This fee can be paid by anyone, including the issuer, a broker-dealer, or an investor such as an investment adviser or pension fund. Research reports issued by JMD are performed on behalf of the public, and are not a service to the issuer or to any person or company who enrolls an issuer for research coverage. The analysts are paid in advance to remove any conflict of interest.

The companies that are referenced in the Small Cap Manager interview have not compensated AdviceTrade or JMD for being referenced in the article, but may or may not be enrolled in research coverage with JMD. If JMD provides research coverage for the company, JMD receives no compensation for publication of information about the company in Small Cap Manager, but would have received the prepaid $25,000 fee for research coverage. Please read full disclosure and other reports and notes on the JMD companies mentioned at www.jmdutton.com.

Small Cap Manager is circulated by Executech Financial Advisors, LLC (Executech), a financial publishing company registered with the US Securities and Exchange Commission under the 1940 Investment Advisors Act as a Registered Investment Advisor. Principals of Executech are also registered representatives of NASD member Broker Dealers which could be construed to be a conflict of interest. Principals of Executech do not own or trade shares in the companies mentioned herein nor do they manage accounts or trade securities for customers as a function of their professions. Executech has not been paid a fee of any kind for the publication of this issue of Small Cap Manager and has circulated this publication as a public service.

Communications from Executech are for informational purposes only. Statements made by various companies, authors, sponsors and/or other contributors do not necessarily reflect the opinions of Executech, and should not be construed as an endorsement by Executech, either expressed or implied. This communication is not intended to be construed as an offering or a solicitation of an offer to buy or sell securities mentioned or disclosed. Executech is not responsible for typographical errors or other inaccuracies in content. However, errors may occasionally occur. We believe the information contained herein to be accurate and reliable, but we have made no attempt to obtain independent verification of said information. Therefore, all information and materials are provided "AS IS" without any warranty of any kind. Past results are not necessarily indicative of future results.

Because investing in securities is speculative and carries a high degree of risk, readers are advised to verify all claims and perform their own due diligence before investing in any securities, including any mentioned herein. you are further advised to consult your financial services professional before investing in speculative securities.

We encourage our readers to invest carefully and read the Investor Information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. We also strongly recommend that you read the SEC advisory to Investors concerning Internet Stock Fraud, which can be found at www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's Edgar page. The NASD has published information on how to invest carefully at its web site.